Table 8.
Association between clinical characteristics and antimicrobial resistance patterns among patients with urosepsis (N = 168).
| Studied variables | Negative (N = 77) |
ESBL (N = 37) |
MDR (N = 42) |
MRSA (N = 12) |
P-value | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | |||
| Age (years) mean ± SD | 56.6 ± 14.2 | 54.2 ± 16.7 | 59.0 ± 16.2 | 50.2 ± 18.1 | 0.344 | |||||
| Sex | Female | 20 | 40.8% | 11 | 22.4% | 13 | 26.5% | 5 | 10.2% | 0.729 |
| Male | 57 | 47.9% | 26 | 21.8% | 29 | 24.4% | 7 | 5.9% | ||
| BMI (kg/m 2 ) | 24.6 ± 2.4 | 24.6 ± 1.6 | 24.1 ± 2.1 | 23.6 ± 2.1 | 0.274 | |||||
| History of congenital anomalies | 4 | 40.0% | 4 | 40.0% | 2 | 20.0% | 0 | 0.0% | 0.490 | |
| Stone former | 11 | 52.4% | 5 | 23.8% | 3 | 14.3% | 2 | 9.5% | 0.697 | |
| History of surgical intervention | 53 | 48.6% | 24 | 22.0% | 25 | 22.9% | 7 | 6.4% | 0.747 | |
| CAUTI | 76 | 45.8% | 37 | 22.3% | 41 | 24.7% | 12 | 7.2% | > 0.999 | |
| Presence of renal abscess | 19 | 43.2% | 13 | 29.5% | 9 | 20.5% | 3 | 6.8% | 0.559 | |
| Presence of perinephric abscess | 12 | 44.4% | 5 | 18.5% | 9 | 33.3% | 1 | 3.7% | 0.639 | |
| Presence of a DJ stent | 8 | 32.0% | 10 | 40.0% | 6 | 24.0% | 1 | 4.0% | 0.108 | |
| Presence of a nephrostomy tube | 19 | 59.4% | 3 | 9.4% | 6 | 18.8% | 4 | 12.5% | 0.076 | |
| History of DM | 23 | 48.9% | 10 | 21.3% | 10 | 21.3% | 4 | 8.5% | 0.878 | |
| History of HTN | 31 | 50.8% | 13 | 21.3% | 14 | 23.0% | 3 | 4.9% | 0.710 | |
| History of cardiac diseases | 8 | 66.7% | 3 | 25.0% | 1 | 8.3% | 0 | 0.0% | 0.266 | |
| History of hepatic diseases | 3 | 50.0% | 1 | 16.7% | 1 | 16.7% | 1 | 16.7% | 0.848 | |
| History of renal diseases | 6 | 50.0% | 2 | 16.7% | 2 | 16.7% | 2 | 16.7% | 0.544 | |
ESBL, extended-spectrum β-lactamase; MDR, multidrug-resistant; MRSA, methicillin-resistant Staphylococcus aureus; BMI, body mass index; CAUTI, catheter-associated urinary tract infection; DJ, double-J; DM, diabetes mellitus; HTN, hypertension; SD, standard deviation.